Breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female patients aged >= 18 years; 2. Histopathologically confirmed invasive breast cancer; 3. Scheduled to receive standard neoadjuvant or adjuvant chemotherapy based on anthracyclines and/or taxanes, comprising =6 cycles; 4. Conscious with normal comprehension and communication abilities; 5. Informed consent obtained and voluntarily signed.
Exclusion criteria
Exclusion criteria: 1.Combined with other primary malignant tumors; 2.Patients with severe cardiac, hepatic, and renal insufficiencies, which are contraindications to chemotherapy, are included; 3. Those with severe cognitive impairment or mental illnesses (such as dementia, schizophrenia, etc.) who are unable to cooperate with the study; 4.Participate in other intervention clinical studies at the same time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| psychological resilience; | — |
Secondary
| Measure | Time frame |
|---|---|
| social support;self-efficacy;positive and negative emotions; | — |
Countries
China
Contacts
The First Affiliated Hospital of Wenzhou Medical University